Registration Header
REGISTER TODAY!

Lacto…WHAT…cillus? What happened to my Lactobacillus probiotics?

 
ALREADY REGISTERED?

CONNECT

Facebook LinkedIn Twitter Instagram

Start Date:6/22/2020

Start Time:11:00 AM EDT

Duration:60 minutes

Abstract:

It finally happened.

Over two years of hearing of this, it finally happened. In 2019 there were over 255 species of the genus Lactobacillus which had been named for the same common property of lactic acid production from sugars.

Today the nomenclature of the genus Lactobacillus, together with some other related taxa has been revisited. The single genus has been split into 25 genera. The real purpose of classifying living things is to improve communication. We like to know what we are dealing with hence we need to be able to talk and communicate about it in the proper names.

This second webinar in the IPA series will deal with the reclassification of the Lactobacillus genus and its implications to the industry and offer strategies your company can implement to hopefully facilitate the change.

Speakers

Dr Bruno Pot

Guest Professor
Vrije Universiteit Brussel

Bruno graduated from the University of Gent, Belgium. In subsequent postdocs he performed research on lactic acid bacteria. In 1997 he joined the company Yakult as science manager Benelux. Between 2001–2016 he worked as Research Director at the Institut Pasteur in Lille, as Director of Business Development at the bioinformatics company Applied Maths NV. Until today he is Guest Professor at the Vrije Universiteit Brussel. Since 2016 Bruno is back with Yakult as Science Director Europe. He is member of the Taxonomic Subcommittee for Lactobacillus and Bifidobacterium, President of the Pharmabiotic Research Institute, and board member of ILSI-EU and the LABIP.

Dr Cara Welch

Deputy Director, Office of Dietary Supplement Programs
Center for Food Safety and Applied Nutrition

Cara is currently the Deputy Director for the Office of Dietary Supplement Programs (ODSP) in FDA’s Center for Food Safety and Applied Nutrition (CFSAN). In this role, Dr. Welch leads the development of new policies and programs involving regulatory compliance and provides scientific expertise for emerging issues affecting the dietary supplement industry. She is also responsible for prioritization and execution of ODSP’s research portfolio. Prior to returning to ODSP, she was on detail as a Special Assistant to the Deputy Commissioner for Policy, Legislation, and International Affairs in the Office of the Commissioner. In this role, she provided expertise on agency level food policy issues. Prior to joining FDA, Welch was the Senior Vice President of Scientific and Regulatory Affairs at the Natural Products Association. Welch earned her Ph.D. in Medicinal Chemistry from Rutgers University working with traditional medicinal African plants.

Amy Summers

President
Pitch Publicity

Amy Summers launched Pitch Publicity in 2003, in the face of a rapidly changing climate for communication and media relations. She has 20 years experience in securing publicity and developing communication strategies for influential experts in natural health and medicine, science, tech and finance for both international corporations and non-profit organizations. Summers’ campaigns have resulted in billions of media impressions worldwide and she’s credited as the first to strategize live media interviews at both the deepest and highest points of the planet (scientific laboratory Aquarius, 63 feet beneath the sea; and Mount Everest summit, 21,000 feet above sea level). She earned her Bachelor of Science degree in Public Relations, with minor in Health Science Education, from the University of Florida; serves on UF Alumni Association national board of directors and UF College of Journalism and Communications Public Relations Advisory Council. Summers produces on of the most highly ranked communications flash briefing called, “The Pitch with Amy Summers,” heard on Amazon’s Alexa and Google Home, and is the first published smart voice course available through her educational communications company, INICIVOX, designed to inspire and strengthen soft skill learning.

Solange Henoud

Global Regulatory Affairs Director
Lallemand Health Solutions

Solange Henoud leads regulatory affairs at the global level at Lallemand Health Solutions, actively represents the company in trade associations and is chair of the regulatory affairs committee at the International Probiotics Association (IPA). Henoud has been involved in many successful company and industry initiatives advocating probiotics to Health authorities such as Health Canada, the US Food and Drug Administration, the Brazilian Agência Nacional de Vigilância Sanitària, the Argentinian Legislation and Standarization of National Food Institute, Europe, Asia and other regulatory bodies over the globe. The achievements she is mostly proud of with her team are the specific health claims in various indications approved for Lallemand products and the footprint Lallemand products have in more than 54 countries under different regulatory categories including supplements, foods, food for special purposes and drugs. She has worked at Lallemand for 12 years after entering the regulatory affairs arena when immigrated to Canada from her native Lebanon where she studied science, architecture and ran her own practice.

Richard Cleland

Assistant Director
FTC Division of Advertising Practices, Bureau of Consumer Protection

Mr. Cleland joined the Federal Trade Commission’s Division of Advertising Practices in 1991. In 1996, Mr. Cleland was appointed Assistant to the Director of the Bureau of Consumer Protection and, in 1998, he was appointed Assistant Director of the Division of Service Industry Practices. He currently serves as Assistant Director of the Division of Advertising Practices. His primary area of expertise is the advertising and marketing of health-related products and services. He also supervises many of the Commission’s health fraud and weight-loss product and service law enforcement initiatives. Mr. Cleland supervised the FTC’s review of the Endorsement and Testimonial Guides. He recently supervised the revision of the FTC’s guidance on making effective disclosures on the Internet and other digital platforms (.com Disclosures). Prior to joining the Federal Trade Commission, Mr. Cleland served as Special Assistant Attorney General and Director of the Division of Consumer Protection in the Iowa Attorney Generals Office.




First Name

SIGN UP

Last Name
Job Title
Company
Work Phone
Email Address
Country
Got a burning question about this topic? Send it to us using the box below and we will try to have it answered by our expert panellists. You are also welcome to ask questions on the live day.

This webinar is a free service provided to you by William Reed Business Media Ltd and this service is produced by the International Probiotics Association. In order for you to receive this content, the above data is provided to the International Probiotics Association, the content producer.

William Reed Business Media Ltd. may use your contact data to keep you informed of its products and services by email or by phone. You can withdraw your marketing consent at any time by clicking the unsubscribe link in such email or by sending an email to dataprivacy@wrbm.com


More information on our processing can be found in our Privacy Notice. By submitting this form, you acknowledge that you have read and understand our Privacy Notice